Predicting Relapse in Patients With Medulloblastoma by Integrating Evidence From Clinical and Genomic Features

Predicting Relapse in Patients With Medulloblastoma by Integrating Evidence From Clinical and Genomic Features

PURPOSE: Despite significant progress in the molecular understanding of medulloblastoma, stratification of risk in patients remains a challenge. Focus has shifted from clinical parameters to molecular markers, such as expression of specific genes and selected genomic abnormalities, to improve accura...

Full description

Saved in:
Bibliographic Details
Main Authors: Tamayo, Pablo, Cho, Yoon-Jae, Tsherniak, Aviad, Greulich, Heidi, Ambrogio, Lauren, Schouten-van Meeteren, Netteke, Zhou, Tianni, Buxton, Allen, Kool, Marcel, Meyerson, Matthew, Pomeroy, Scott L., Mesirov, Jill P.
Format: Text
Language:English
Published: American Society of Clinical Oncology 2011
Subjects:
Original Reports
Online Access:https://pmc.ncbi.nlm.nih.gov/articles/PMC3082982/
https://pubmed.ncbi.nlm.nih.gov/21357789
http://dx.doi.org/10.1200/JCO.2010.28.1675
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://pmc.ncbi.nlm.nih.gov/articles/PMC3082982/
https://pubmed.ncbi.nlm.nih.gov/21357789
http://dx.doi.org/10.1200/JCO.2010.28.1675

Similar Items